Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases.
about
Intestinal fibrosis: ready to be reversed.Hypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier Function.Factors Promoting Development of Fibrosis in Crohn's Disease.Editorial: Factors Promoting Development of Fibrosis in Crohn's Disease.NF-E2-Related Factor 2 Suppresses Intestinal Fibrosis by Inhibiting Reactive Oxygen Species-Dependent TGF-β1/SMADs Pathway.Myeloid differentiation primary response gene (MyD) 88 signalling is not essential for intestinal fibrosis development.Redox Imbalance in Intestinal Fibrosis: Beware of the TGFβ-1, ROS, and Nrf2 Connection.Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation.Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.miR-200b-containing microvesicles attenuate experimental colitis associated intestinal fibrosis by inhibiting epithelial-mesenchymal transition.Ultrasound Elasticity Imaging Predicts Therapeutic Outcomes of Patients With Crohn's Disease Treated With Anti-Tumour Necrosis Factor Antibodies.Activation of Myofibroblast TRPA1 by Steroids and Pirfenidone Ameliorates Fibrosis in Experimental Crohn's Disease.TRPing Up Fibrosis: A Novel Role for TRPA1 in Intestinal Myofibroblasts.Managing Intestinal Fibrosis in Patients With Inflammatory Bowel Disease.Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosisAn expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease
P2860
Q39237846-0D49B18F-C912-4C5D-844C-E441BAA251FAQ39277299-4F14E90D-E303-4DA2-A7CE-657810DAF8EBQ39453646-35B8B670-A4C4-4F8B-83D3-1EE0226EE919Q42368405-A947052A-FEDC-4371-94EC-E94F0834F4AFQ46319948-EFF3A614-F93B-4BF4-86B6-3DA6F8CABB49Q47144405-5FBFA650-DE83-4FE3-B24A-4578A3F88E11Q47259299-D727544E-DA53-4502-866C-41FB4BC4BF3BQ48092209-663546FB-12D9-42AA-A413-0B2CB138B397Q48287325-5123F85F-2851-4058-AEB6-095F863977A4Q51074830-0EA56582-FACD-48EC-A4DA-D26FF5E8E9ECQ51806472-77C90910-4FD3-4D9A-BA87-2EE28C99B477Q52430882-8A6D6B60-F22A-4621-9C14-116913C9C8C6Q52649428-DB8DDDC8-4531-4199-9A1F-95C071A62B4FQ54966510-425AEB01-AD9C-4B8D-8A9D-46AADC067699Q57472735-DE613483-E4BB-431F-B737-A0641E1E1C43Q57943350-E3630BC7-312B-469D-9365-8C55724C98C4
P2860
Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Mechanisms, Management, and Tr ...... h Inflammatory Bowel Diseases.
@en
type
label
Mechanisms, Management, and Tr ...... h Inflammatory Bowel Diseases.
@en
prefLabel
Mechanisms, Management, and Tr ...... h Inflammatory Bowel Diseases.
@en
P2860
P1433
P1476
Mechanisms, Management, and Tr ...... h Inflammatory Bowel Diseases.
@en
P2093
Claudio Fiocchi
Florian Rieder
P2860
P304
340-350.e6
P356
10.1053/J.GASTRO.2016.09.047
P407
P577
2016-10-05T00:00:00Z